CARA KRAUS: Open Payments
NPI 1376058594 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,203 in 173 payments from 24 companies in 2025. Trend: 2023 $2,815 · 2024 $3,031 · 2025 $3,203
Food & beverage: $3,203
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $579 |
| Novo Nordisk Inc | 27 | $466 |
| PFIZER INC. | 21 | $348 |
| Lilly USA, LLC | 15 | $274 |
| GlaxoSmithKline, LLC. | 20 | $250 |
| AstraZeneca Pharmaceuticals LP | 12 | $222 |
| Exact Sciences Corporation | 8 | $212 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $68 |
Products named: UBRELVY, VRAYLAR, Wegovy, NURTEC ODT, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Rybelsus, JARDIANCE.
Industry payments across PA — which companies pay providers there.
